Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2020 May 18;12(4):322-325.
doi: 10.1093/jmcb/mjaa014.

Treating COVID-19 with Chloroquine

Mingxing Huang  1   2 , Tiantian Tang  3   4 , Pengfei Pang  2   5 , Man Li  2   6 , Ruolan Ma  7   8 , Jiahui Lu  1 , Jingxian Shu  9 , Yingying You  10 , Binghui Chen  11 , Jiabi Liang  9 , Zhongsi Hong  1 , Huili Chen  1 , Ling Kong  12 , Dajiang Qin  12   7 , Duanqing Pei  12   7 , Jinyu Xia  1 , Shanping Jiang  3   4 , Hong Shan  2   5
Affiliations
Clinical Trial

Treating COVID-19 with Chloroquine

Mingxing Huang et al. J Mol Cell Biol. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall study plan and efficacy results. (A) Patient screening and enrollment flow chart. (B) Cumulative incidence of virologic, clinical, and imaging outcomes. Red color indicates Chloroquine, while blue indicates Lopinavir/Ritonavir. (C) Square root and logarithmic (base 10) transformation were applied to normalize the distribution of CD3+, CD4+, and CD8+ T-cell count data. Missing values of CD3+, CD4+, and CD8+ T-cell counts were imputed by Kalman smoothing on a structural model. The trajectories (with 95% confidence bands) in the Chloroquine group were derived with the use of linear mixed effects model.
See this image and copyright information in PMC

References

    1. Delvecchio R., Higa L.M., Pezzuto P., et al. (2016). Chloroquine, an endocytosis blocking agent, inhibits Zika virus infection in different cell models. Viruses. 8, 322. - PMC - PubMed
    1. Keyaerts E., Vijgen L., Maes P., et al. (2004). In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem. Biophys. Res. Commun. 323, 264–268. - PMC - PubMed
    1. Kono M., Tatsumi K., Imai A.M., et al. (2008). Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK. Antivir. Res. 77, 150–152. - PMC - PubMed
    1. Lu H., Stratton C.W., and Tang Y.W. (2020). Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J. Med. Virol. 92, 401–402. - PMC - PubMed
    1. Savarino A., Di Trani L., Donatelli I., et al. (2006). New insights into the antiviral effects of chloroquine. Lancet Infect. Dis. 6, 67–69. - PMC - PubMed

Publication types